Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Effetti degli Esercizi Fun-Core (Stabilizzazione del Core a Misura di Bambino) sull'Equilibrio e la Mobilità Funzionale nei Bambini con Paralisi Cerebrale Spastica

17 settembre 2026 aggiornato da: Berk Korkut, Istanbul University

Effetti degli Esercizi Fun-Core (Stabilizzazione del Core a Misura di Bambino) sull'Equilibrio e la Mobilità Funzionale in Bambini con Paralisi Cerebrale Spastica: Uno Studio Controllato Randomizzato in Singolo Cieco

A total of 54 children, aged between 6 and 12 years, diagnosed with hemiplegic cerebral palsy and not meeting the exclusion criteria, who registered at the outpatient clinics of the Department of Physical Medicine and Rehabilitation, Istanbul University, Istanbul Faculty of Medicine, between June 1, 2025 and March 1, 2026, were planned to be included in our thesis study, which was planned to be prospective, randomized and single-blind. Children and their parents will be informed verbally and in writing about the study's purpose, duration, and method of implementation, and their informed consent will be obtained. They will be asked to sign an "Informed Consent Form." Patient assessment and follow-up forms will be completed at pre- and post-treatment follow-ups. Patients who meet the inclusion criteria will be numbered according to their order of admission and then randomly assigned to either the intervention or control groups by a computer program.

In addition to a brochure showing the number of sets and repetitions to be given to the patients as a standard home exercise program, the Fun-Core video exercise program, designed as a child-friendly core stabilization exercise program to be performed 3 times a week, will be given to the intervention group (G1), and the exercises will be delivered to the participants through a website with special accounts.

The control group (G2) will receive a standard home exercise program in brochure format, showing the number of sets and repetitions. The exercise program will be performed at home three times a week for 8 weeks.

Panoramica dello studio

Stato

Completato

Condizioni

Intervento / Trattamento

Tipo di studio

Interventistico

Iscrizione (Effettivo)

54

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • Fatih
      • Istanbul, Fatih, Turchia (Türkiye)
        • Istanbul Unıversity, Istanbul Faculty of Medicine, Department of Physical Medicine and Rehabilitation

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 6 anni a 12 anni (Bambino)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Children with hemiplegic cerebral palsy between the ages of 6 and 12
  • Children with Gross Motor Function Classification System (GMFCS) Levels 1, 2, and 3
  • Shoe sizes 30 and above

Exclusion Criteria:

  • Cognitive impairments that prevent understanding and performing simple commands and tasks
  • Botulinum toxin injections into the upper and/or lower extremities within the last 6 months
  • History of lower extremity or lumbar surgery within the last year
  • Presence of uncontrolled severe epileptic seizures
  • Presence of severe vision or hearing problems
  • Presence of fixed contractures in the lower extremities

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Comparatore attivo: Intervention Group (G1)

In addition to a brochure showing the number of sets and repetitions to be given to the patients as a standard home exercise program, the Fun-Core video exercise program, designed as a child-friendly core stabilization exercise program to be performed 3 times a week, will be given to the intervention group (G1), and the exercises will be delivered to the participants through a website with special accounts.

Fun-Core Exercises will be narrated, prepared and recorded in video format, and then delivered in order to ensure children's development and motivation.

Standard home based exercise program

Altro: Control Group (G2)

Standard home exercise program (brochure)

Fun-Core Exercises will be narrated, prepared and recorded in video format, and then delivered in order to ensure children's development and motivation.

Standard home based exercise program

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Modified Timed Up & Go Test
Lasso di tempo: Day 1 (before starting treatment), Day 60 (end of treatment), Day 90 (one month after the end of treatment)

The mTUG test is a modified version of the Timed Up and Go (TUG) test for assessing functional mobility in children. It essentially measures how quickly an individual can perform the skills necessary for daily living activities-sitting, standing, walking, turning, and sitting down again. Unlike the standard TUG test, it includes instructions and environmental conditions tailored to the developmental level and cognitive capacity of children. In our study, the mTUG test will be administered to participants wearing shoes equipped with wearable sensors, and the test duration will be measured through the shoes.

Day 1 (before starting treatment), Day 60 (end of treatment), Day 90 (one month after the end of treatment)

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Six Minute Walk Test
Lasso di tempo: Day 1 (before starting treatment), Day 60 (end of treatment), Day 90 (one month after the end of treatment)

It is considered a measurement that assesses an individual's overall functional status. The test assesses the integrated response of respiratory, cardiovascular, skeletal, nervous, and muscular components. A 30-meter track will be used for the test. The total distance walked by the participant over 6 minutes will be recorded in meters. In our study, the 6-minute walk test will be administered to participants wearing shoes equipped with wearable sensors, and the test will be measured through the shoe.

Day 1 (before starting treatment), Day 60 (end of treatment), Day 90 (one month after the end of treatment)
Pediatric Balance Scale
Lasso di tempo: Day 1 (before starting treatment), Day 60 (end of treatment), Day 90 (one month after the end of treatment)

It will be used to assess balance in children. It consists of 14 items, each item being scored from 0 to 4. The maximum score is 56. The higher the score, the better the child's balance. 1.sitting to standing 2.standing to sitting 3.transfers 4.standing unsupported 5.sitting unsupported 6.standing with eyes closed 7.standing with feet together 8.standing with one foot in front 9.standing on one foot 10.turning 360 degrees 11.turning to look behind 12.retrieving object from floor 13.placing alternate foot on stool 14.reaching forward with outstretched arm

Day 1 (before starting treatment), Day 60 (end of treatment), Day 90 (one month after the end of treatment)
Trunk Endurance Tests
Lasso di tempo: Day 1 (before starting treatment), Day 60 (end of treatment), Day 90 (one month after the end of treatment)

Performance assessment is conducted by recording the maximum time the individual can maintain the test position. Before each test, the child is asked to maintain the test position for as long as possible. Each test will be repeated three times, and the average time will be recorded. To minimize the risk of injury or psychological distress, the tests will be explained in detail to the children beforehand, and their administration will be demonstrated. Two healthcare professionals will be present during each test to ensure the child maintains proper form and ensure safety.

Back extension test: Biering-Sørensen position with trunk held horizontal, pelvis/legs strapped; ended at loss of position or 300s.

Lateral torso test: Full side-bridge with straight body on elbow; stopped when posture broke or 300s.

Flexor test: Sit-up at 50° support, arms crossed, feet secured; ended when back touched support or 300s.

Day 1 (before starting treatment), Day 60 (end of treatment), Day 90 (one month after the end of treatment)
Pediatric Reach Test
Lasso di tempo: Day 1 (before starting treatment), Day 60 (end of treatment), Day 90 (one month after the end of treatment)

It is a measurement method that evaluates the dynamic component of balance. The test will be conducted by measuring the distance in centimeters that participants can reach forward, then to the right and left, without lifting their heels while standing upright. The procedures will be explained to participants once, and then they will be asked to perform the exercise three times. They will be expected to hold each position for at least 3 seconds. Measurements where participants lose their balance and lift their feet off the ground will be invalid. The distance reached will be measured in centimeters using a non-stretchable tape measure.

The test consists of two sections: sitting and standing, with three items in each section (six items in total). The total score is calculated by measuring the distance in centimeters between the starting position (shoulder flexed 90° for forward reach and shoulder abducted 90° for side reach) and the maximum stable reach.

Day 1 (before starting treatment), Day 60 (end of treatment), Day 90 (one month after the end of treatment)
WeeFIM
Lasso di tempo: Day 1 (before starting treatment), Day 60 (end of treatment), Day 90 (one month after the end of treatment)

The WeeFIM is used to measure functional independence in activities of daily living for children aged 6 months to 12 years. It consists of 18 items covering self-care, toilet control, mobility, locomotion, communication, and social development.

A 7-level ordinal rating system ranging from 7 (complete independence) to 1 (total assistance), is used to score performance in each item. As with the FIM, the Wee- FIM consists of two dimensions: motor and cognitive.

The WeeFIM is a reliable and valid tool for assessing the functional status of children with CP.

Day 1 (before starting treatment), Day 60 (end of treatment), Day 90 (one month after the end of treatment)
PEDQoL 4.0 Pediatric Quality of Life Questionnaire
Lasso di tempo: Day 1 (before starting treatment), Day 60 (end of treatment), Day 90 (one month after the end of treatment)

The PEDQoL 4.0 Pediatric Quality of Life Questionnaire will be used. Depending on the participant's age, the child report and parent report forms will be used for children aged 7 and 8, and the child report and parent report forms for children aged 8-12. It is designed to measure core health dimensions defined by the World Health Organization (WHO). It is administered in parallel in child self-report and parent proxy report formats. The participant is asked how much of a problem each item has been in the past month.

Participants are asked to rate how problematic each item has been during the past month. Reverse scoring is applied and converted to a 0-100 scale: 0 = 100 points, 1 = 75 points, 2 = 50 points, 3 = 25 points, and 4 = 0 points. The total scale score is calculated by dividing the sum of responses by the number of items answered. If more than 50% of the items are missing, the scale score is not computed.

Day 1 (before starting treatment), Day 60 (end of treatment), Day 90 (one month after the end of treatment)
Children/ Youth with Cerebral Palsy Brief (6-13 years of age)
Lasso di tempo: Day 1 (before starting treatment), Day 60 (end of treatment), Day 90 (one month after the end of treatment)

Activity and Participation Assessment: Will be evaluated with the Brief ICF Core Set for Children and Adolescents with CP (≥6, <14 Years). Difficulty levels will be evaluated using the ICF Qualifiers. A score of 0 indicates no difficulty (0-4%), 1 mild difficulty (5-24%), 2 moderate difficulty (25-49%), 3 severe difficulty (50-95%), and 4 complete difficulty (96-100%). Scores 8 ("not specified") and 9 ("not applicable") are used when relevant.

Activity and participation will be assessed under the domains of performance and capacity. Higher scores in each parameter indicate greater limitation.

Day 1 (before starting treatment), Day 60 (end of treatment), Day 90 (one month after the end of treatment)

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Investigatori

  • Cattedra di studio: Ayse R Aydin, MD, Prof., Istanbul University Istanbul Medical Faculty, Department of Physical Medicine and Rehabilitation

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

20 novembre 2025

Completamento primario (Effettivo)

7 agosto 2026

Completamento dello studio (Effettivo)

7 agosto 2026

Date di iscrizione allo studio

Primo inviato

29 settembre 2025

Primo inviato che soddisfa i criteri di controllo qualità

16 novembre 2025

Primo Inserito (Effettivo)

18 novembre 2025

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

22 settembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

17 settembre 2026

Ultimo verificato

1 novembre 2025

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • E-29624016-050.99-3354321

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .